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Podocyte loss plays a pivotal role in the pathogenesis of glomerular disease. However,
the mechanisms underlying podocyte damage and loss remain poorly understood.
Although detachment of viable cells has been documented in experimental Diabetic
Nephropathy, correlations between reduced podocyte density and disease severity have
not yet been established. YAP, a mechanosensing protein, has recently been shown to
correlate with glomerular disease progression, however, the underlying mechanism has
yet to be fully elucidated. In this study, we sought to document podocyte density in
Diabetic Nephropathy using an amended podometric methodology, and to investigate
the interplay between YAP and cytoskeletal integrity during podocyte injury. Podocyte
density was quantified using TLE4 and GLEPP1 multiplexed immunofluorescence.
Fourteen Diabetic Nephropathy cases were analyzed for both podocyte density and
cytoplasmic translocation of YAP via automated image analysis. We demonstrate a
significant decrease in podocyte density in Grade III/IV cases (124.5 per 106 µm3)
relative to Grade I/II cases (226 per 106 µm3) (Student’s t-test, p < 0.001), and
further show that YAP translocation precedes cytoskeletal rearrangement following
injury. Based on these findings we hypothesize that a significant decrease in podocyte
density in late grade Diabetic Nephropathy may be explained by early cytoplasmic
translocation of YAP.
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INTRODUCTION
Podocytes serve as the final barrier to protein loss in vivo. The complex cytoarchitecture of
podocytes, consisting of interdigitated foot processes, constitutes the final filtration barrier on the
glomerular basement membrane (Pavenstadt et al., 2003). The specialized 40 nm slit diaphragm
between podocytes allows for the formation of urine ultrafiltrate while retaining albumin and other
essential macromolecules within the blood (Benzing, 2004).
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Glomerular diseases including Diabetic Nephropathy and
Focal Segmental Glomerulosclerosis (FSGS) are characterized
by podocyte loss, resulting in proteinuria (Kihara et al., 1997;
Vogelmann et al., 2003; Petermann et al., 2004), defined by
loss of more than 3 grams of albumin in the urine per 24 h.
This is the primary clinical presentation of glomerular disease
(Khanna, 2011). Proteinuria is known to result from disruption
of the glomerular filtration barrier due to mislocalization of
slit diaphragm proteins such as nephrin, podocin, and CD2AP
(Miner, 2002; Zhang et al., 2004; Fukasawa et al., 2009).
Moreover, foot process effacement, loss of negative charge
at the filtration barrier, impaired endothelial cell integrity,
and podocyte hypertrophy can further contribute to impaired
glomerular filtration in vivo (Saleem, 2015).
It has been shown that reduction in podocyte number is a
direct predictor of the extent of segmental scarring that occurs in
FSGS (Kriz, 2003; Wharram et al., 2005). Reduction in podocyte
number in glomerular disease has been attributed to apoptosis,
autophagy, and detachment from the glomerular basement
membrane, however, the mechanisms underlying podocyte
injury (Kopp et al., 2020) remain largely unknown (Kretzler et al.,
1994; Kriz et al., 1994, 1998; Shankland, 2006). While direct
relationships between podocyte depletion and progression of
glomerulosclerosis have been documented in the PAN-treated rat
(Kim et al., 2001), in Diphtheria toxin-induced podocyte injury
models (Wharram et al., 2005), and in Angiotensin II-induced
injury models (Fukuda et al., 2012), analysis of correlations
between podocyte density and disease progression in clinical
tissue is limited in Diabetic Nephropathy, where biopsies are
not routine clinical practice. However, a recently developed
podometric methodology (Venkatareddy et al., 2014) allows for
quantification of podocyte density based on staining of a single
histologic section. While this technique has been highlighted as
a potential tool for monitoring glomerular disease progression
(Kikuchi et al., 2015), there remains a need to better understand
the mechanisms preceding podocyte detachment in vivo.
The pathophysiological steps preceding podocyte detachment
have been documented extensively by Kriz et al. (1998), Kriz
(2002), and Kriz and LeHir (2005) wherein altered slit diaphragm
integrity and cytoskeletal rearrangement have been highlighted as
primary effects of podocyte injury. Recently, the mechanosensing
protein and Hippo pathway effector, YAP, has emerged as
an integral player in mediating the podocyte stress response
(Schwartzman et al., 2016; Rinschen et al., 2017; Bonse et al.,
2018). Podocyte-specific silencing of YAP in vivo results in FSGS
(Schwartzman et al., 2016), while podocyte injury stimulates
expression of YAP and YAP target genes in a rat model of
glomerular disease (Rinschen et al., 2017). The effects of injury
on YAP activation in podocytes is substrate-dependent, as a stiff
substrate reduced YAP expression in cultured podocytes, whereas
a soft substrate stimulated YAP (Rinschen et al., 2017). Recently
nuclear YAP was identified as a key regulator of glomerular
function (Bonse et al., 2018), where the authors showed that
activation of the Hippo pathway leads to a YAP-dependent
reduction in podocyte viability.
In light of the emerging role of YAP as a mechanosensing
mediator in podocytes, we were interested in whether YAP
cytoplasmic translocation in response to injury occurred
prior to cytoskeletal rearrangement. Since recent reviews have
highlighted the pivotal role of podocytes in the progression
of Diabetic Nephropathy (Carney, 2017; Dai et al., 2017), we
asked whether we could employ podometric methodology using
transducin-like enhancer of split 4 (TLE4) as a nuclear podocyte-
specific marker, and glomerular epithelial protein-1 (GLEPP1),
a glomerular marker to quantify podocyte density in Diabetic
Nephropathy tissue, and further assess the same cohort for
expression and localization of YAP.
MATERIALS AND METHODS
Patients
De-identified tissue specimens from 14 adult patients treated
at the Edinburgh Royal Infirmary, and diagnosed with Diabetic
Nephropathy with no concomitant systemic disease were used for
this study. Cases were released under the Ethics of NHS Lothian
Bioresource. The estimated glomerular filtration rate (eGFR) was
calculated using the following formula: mL/min/m2. The degree
of hematuria was scored as previously described (Hara et al.,
1998). Clinical data for the patients in this cohort is shown in
Table 1. Of the patients, 11 were male and 3 were female. For
histological grading, 7 were classified as Grade I/II and 7 were
Grade III/IV. Proteinuria was reported in clinical charts as 1+,
2+, or 3+ g per day as shown in Supplementary Table 1.
Renal Histological Findings
Tissue sections used for light microscopy were stained with
hematoxylin & eosin (H&E) and periodic acid-Schiff (Brahler
et al., 2012). Pathological parameters were analyzed according
to the criteria for grading Diabetic Nephropathy as outlined by
Tervaert et al. (2010). Histology was assessed for IFTA (0–3),
Interstitial inflammation (0–2), Arteriolar hyalinosis (0–2), and
Arteriosclerosis (0-2). Severity of disease was graded based on
the following criteria noted in the pathology report at the time
of biopsy: Grade I: mild or non-specific light microscopy changes
and EM-proven GBM thickening. GBM > 395 nm in female




Sex (M/F) 11 / 3 7 / 0 4 / 3
Age (years) 60.07 ± 2.50 61.86 ± 3.37 58.29 ± 3.84
s-Cr (mg/dL) 2.5 ± 0.56 1.69 ± 0.35 3.44 ± 1.07
eGFR (mL/min/1.73m2) 35 ± 5.49 41.57 ± 6.67 27.33 ± 8.51
Proteinuria (g/day) 1.54 ± 0.27 0.96 ± 0.31 2.11 ± 0.35*
Hematuria (scores 0–4) 0.5 ± 0.17 0.33 ± 0.21 0.64 ± 0.28
Data shown are mean ± SD. M, male; F, female; S-Cr, serum-creatinine; eGFR,
estimated glomerular filtration rate. Hematuria score: 0 for 0–5 red blood cell/high-
powered field (RBC/HPF), 0.5 for 6-10 RBC/HPF, 1.0 for 11-30 RBC/HPF, 2.0 for
31-100 RBC/HPF, 3.0 for > 100 RBC/HPF, 4.0 for numerous RBC/HPF.
*p < 0.05 Grade I/II vs. III/IV.
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and > 430 nm in males. Grade IIa: Mild mesangial expansion
in > 25% of the observed mesangium. Grade IIb: Severe
mesangial expansion in > 25% of the observed mesangium.
Grade III: Nodular sclerosis (Kimmelstiel-Wilson lesion) with at
least one convincing lesion noted. Grade IV: Advanced diabetic
glomerulosclerosis, with global glomerulosclerosis in > 50% of
all glomeruli (Tervaert et al., 2010).
Primary Antibodies
Mouse monoclonal YAP (1A12) antibody (#12395) was
purchased from Cell Signaling Technology (London,
United Kingdom). TLE4 (E-10) mouse monoclonal antibody
(#sc-365406) was purchased from Insight Biotechnology
(Middlesex, United Kingdom) for identification of podocytes.
For identification of glomeruli, monoclonal mouse anti-human
GLEPP1 (5C11) antibody (#MABS1221) was purchased from
Millipore (Hertfordshire, United Kingdom).
Immunofluorescence of Renal Biopsy
Sections-Tyramide Signal Amplification
for Visualization of Antibody Binding
Formalin-fixed paraffin embedded (FFPE) needle biopsies from
Diabetic Nephropathy patients were cut in 3 µm-thick sections
and put onto frosted charged slides. Slides were incubated at
67◦C overnight prior to use. FFPE sections were de-paraffinized
in fresh xylene for 5 min, thrice. Slides were then rehydrated
in 100% ethanol for 2 min, twice, followed by 2 min in 80%
ethanol, 2 min in 50% ethanol, and 2 min in running tap
water. Antigen retrieval was performed by heating the slides in
a pressure cooker containing sodium citrate/citric acid buffer
(1.8% 0.1M citric acid, 8.2% 0.1M sodium citrate) in distilled
H2O. A pressure cooker containing 1L of sodium citrate/citric
acid buffer was pre-heated in the microwave at high power
for 12 min. Slides were then placed into the pressure cooker
and microwaved at high power for 8 min. Once cooled,
slides were washed twice for 5 min in PBS-T, followed by a
10-min wash in 3% hydrogen peroxide. Slides were washed
twice for 5 min again, and tissue was then outlined with a
Dako hydrophobic pen. Blocking was performed with Dako
Serum-Free Protein Blocking Solution for 10 min prior to
incubation with primary antibodies. Primary antibodies were
diluted in Dako antibody diluent and incubated in a humidity
chamber for 30 min at room temperature, unless otherwise
indicated. Slides were then washed twice for 5 min in PBS-
T and incubated in mouse or rabbit HRP-labeled polymer
solution for 30 min. Slides were then washed in PBS-T for
5 min, twice. Slides were incubated in cyanine 3, cyanine 5,
or FITC Tyramide, respectively (Perkin Elmer, Boston, MA,
United States), diluted in TSA diluent (Perkin Elmer, Boston,
MA, United States) for 10 min in the dark. Slides were then
washed in PBS-T twice for 5 min, and incubated in Hoechst
(1:20) for 10 min in the dark. Following two 5 min PBS-T
washes, slides were dehydrated in 80% ethanol, air dried, and
mounted with ProLong Gold anti-fade mountant (Invitrogen,
United Kingdom). Images were captured and analyzed using an
automated scanning AQUA microscope (McCabe et al., 2005).
Further automated image analysis was performed with Definiens
Tissue Studio software.
Immunofluorescence Multiplexing of
Two or More Same Species Antibodies
Multiplexing of two or more same-species antibodies was
achieved by heat-induced microwave stripping in sodium-citrate
buffer. For this protocol, TSA methodology (McCabe et al., 2005)
was adhered to until the TSA fluorophore incubation step. After
slides were incubated in the indicated fluorophore, slides were
washed twice for 5 min in PBS-T. Sodium citrate buffer was
prepared and pre-heated for 12 min at 100% power in a pressure
cooker without the rubber seal or pressure top to achieve a lower
temperature. Slides were then placed into the pre-heated sodium
citrate buffer and heated in the pressure cooker without the
rubber seal or steam top for 17 min, on the autodefrost, 750G
setting. Slides were then allowed to cool in running tap water for
20 min, and staining with the subsequent primary antibody and
corresponding TSA fluorophore was performed.
Podometric Analysis
The TLE4 method for estimating podocyte density, previously
established by Venkatareddy et al. (2014) was used. The
methodology detailed above for multiplexing with two primary
antibodies was used to co-stain for GLEPP1 and TLE4 via
immunofluorescence to measure podocyte cell area density,
a calculation previously reported by Yang et al. (2015).
Calculation of podocyte nuclear density based on TLE4
immunofluorescence was used as reported by Yang et al. (2015).
GLEPP1 positive percentage tuft area was measured based on
immunofluorescence, similar to the immunoperoxidase method
also reported by Yang et al. (2015). Glomerular tuft volume
calculations were made under the assumption that all glomeruli
are spherical, as previously published (Hodgin et al., 2015).
We adopted the methodologic assumptions used in previously
published podometric analysis (Hodgin et al., 2015). A minimum
of 6 glomeruli per case were evaluated for podometric analysis.
Data acquired from Definiens image analysis was used to
calculate podocyte density using the parameters detailed above.
Definiens Automated Image Analysis
Whole slide images of the immunofluorescence labeled histology
sections were acquired for each fluorescence channel (GLEPP1:
anti-FITC, TLE4: anti-Cy5, DAPI) with an AQUA PM-2000
platform (HistoRX) microscope at 20× magnification, and were
exported without any further processing. Digital image analysis
was performed using Definiens Tissue Studio 4.7 software
(Definiens AG, Munich). Images acquired, as stated above,
were imported into the Tissue Studio software as TIFFs. Tissue
area was automatically detected and identified within each
image. Definiens’ Composer machine learning technology was
utilized to train the algorithm to automatically recognize and
segment regions of interest: non-tissue/background regions, or
glomeruli, based on GLEPP1 staining. Tissue Studio’s nuclear
classification algorithm was used to automatically segment and
classify nuclei within the glomeruli. An intensity threshold
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within the image analysis software was applied to each protein
marker to identify cells positive for YAP (threshold intensity:
75), and TLE4 (threshold intensity: 115). Manual correction
was used to confirm valid separation of these regions into the
correct Regions of Interest (ROI). Co-expression of markers
of interest were next used to classify the nuclei for YAP or
TLE4 positivity. Tissue Studio’s cell classification algorithm
was used to identify number of TLE4 positive cells based
on previously set thresholds. Within this population of cells,
the nuclear algorithm was used to identify number of cells
that were positive for nuclear YAP. These values were then
taken as a percentage of total number of TLE4 positive
cells per glomerulus.
Cell Culture
The human immortalized podocyte cell line (Saleem et al.,
2002) was obtained as a gift from Prof. Moin Saleem (Bristol,
United Kingdom). Proliferating podocytes were cultured at the
permissive temperature of 33◦C, 5% CO2 in RPMI supplemented
with 10% Fetal Bovine Serum (FBS), 1% Penicillin-Streptomycin
(PS), and 1% Insulin-Transferrin-Selenium (ITS). Podocytes
were cultured under differentiation conditions at 37◦C, 5% CO2
for 12 days in RPMI supplemented with 2% FBS, 1% PS, and
1% ITS. For injury, podocytes were treated with Puromycin
Aminonucleoside (PAN) at 25 mg/mL for 24 h, or 30 mM glucose,
or hypoxia (0.5% O2), followed by 5 day washout of injury
condition or return to normoxia.
Immunocytochemistry
Podocytes were cultured on No.2 glass coverslips in 6 well plates.
Cells were washed 2× in PBS, and fixed in 4% paraformaldehyde
(PFA) for 10 min at room temperature. Cells were washed for
5 min in PBS, and permeabilized in PBS supplemented with
0.2% Triton X-100 for 5 min, shaking at 15 rpm. Cells were
then blocked with 5% Bovine Serum Albumin (BSA), 0.1%
Triton X-100 in PBS for 30 min, shaking at 15 rpm. Coverslips
were incubated overnight at 4◦C in primary antibody: Mouse
monoclonal YAP (1A12) antibody (#12395) in 5% BSA, 0.1%
Triton X-100 in PBS. Following incubation in primary antibody,
coverslips were washed 3× 5 min in PBS, shaking at 15 rpm.
Coverslips were incubated in secondary antibody (1:200) Alexa
Fluor 568 goat anti-mouse (Life Technologies United Kingdom,
Z25006) or in Alexa Fluor 647 Phalloidin (Thermo Fisher
Scientific, United Kingdom, A22287) where indicated, in 3%
BSA in PBS for 60 min protected from light. Coverslips were
then washed 5× 5 min in PBS protected from light, shaking
at 15 rpm. Coverslips were mounted on frosted glass slides
with Prolong Gold Antifade Reagent with DAPI (Invitrogen
United Kingdom, P36931). Slides were imaged with a Leica
DM5500 B Microscope.
Statistical Analysis
Data are presented as mean ± SD. Groups were compared using
the unpaired Student’s t-test. All analyses were performed using
Prism/SPSS software. For correlations with clinical parameters,




Decreased Podocyte Density in Diabetic
Nephropathy
Podometric methodology by Hodgin et al. (2015) was
amended and used to estimate podocyte density in a Diabetic
Nephropathy cohort (n = 14). The previously published
podometric methodology requires removal of the coverslip for
peroxidase immunocytochemistry staining of GLEPP1 following
immunofluorescence TLE4 staining. To increase efficiency of
the protocol, we employed immunofluorescence multiplexing
with two primary antibodies for TLE4 and GLEPP1, allowing
the quantification of podocyte number and glomerular tuft
area from a single image (Figure 1A). Using automated image
analysis, glomeruli were segmented as Regions of Interest (ROIs)
based on GLEPP1 staining (Figure 1B), nuclei were segmented
based on Hoechst staining (Figure 1C), and TLE4 expression
was quantified within each nucleus to identify podocytes
(Figure 1D). Since all data was obtained from single images,
we were further able to streamline image analysis by using
Definiens Tissue Studio software which identified all glomeruli
as regions of interest, quantified the number of podocytes
within each glomerulus based on a set threshold for TLE4
staining intensity, and generated output of all data required to
estimate podocyte density, using a previously reported equation
(Venkatareddy et al., 2014).
Diabetic Nephropathy cases were graded based on the
pathological classification system published by Tervaert et al.
(2010), and stratified into Grade I/II (n = 7) vs. Grade
III/IV (n = 7) before being assessed for significant differences
between clinical findings at the time of biopsy (Table 1 and
Supplementary Table 1). Of the 14 cases included, the only
significant difference between clinical parameters in Grade I/II
vs. Grade III/IV was in proteinuria, 0.96 ± 0.31 g/day vs.
2.11± 0.35 g/day (p< 0.05), respectively (Table 1). Otherwise no
significant difference between sex, age, s-Cr, eGFR, or hematuria
was observed between the two groups.
Immunofluorescence labeling of glomeruli with GLEPP1
as a glomerular marker and TLE4 as a podocyte nuclear
marker revealed a decrease in podocyte density in all grades
of Diabetic Nephropathy cases relative to healthy control tissue
(Figures 2A,B). The lowest podocyte density was observed in
Grade 4 Diabetic Nephropathy cases, with podocyte density
gradually decreasing from Grade 1 through Grade 4 as
disease severity increased (Figure 2A). Podocyte nuclear density
decreased by 55% when comparing Grade I/II to Grade III/IV,
with a mean podocyte density of 226 podocytes per 106 µm3
glomerular volume in Grade I/II vs. 124.5 per 106 µm3 in Grade
III/IV (p < 0.001) (Figure 2B). Glomerular volume per podocyte
increased almost two-fold between Grade I/II and Grade III/IV,
with a mean glomerular volume per podocyte of 4.5 × 103 µm3
in Grade I/II cases vs. 8.96 × 103 µm3 in Grade III/IV cases
(p < 0.05) (Figure 2C). Consistent with the decrease in podocyte
nuclear density observed, podocyte number per glomerular tuft
significantly decreased from Grade I/II to Grade III/IV cases,
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FIGURE 1 | Podometric methodology: Incorporation of automated image analysis (A) Representative image of GLEPP1 (red) and TLE4 (green) staining of glomeruli
which was analyzed for podocyte density. (B) Definiens identification of Region of Interest (ROI) (magenta) based on GLEPP1 staining. (C) Hoechst staining is used to
segment nuclei within ROI with Definiens. (D) Within segmented nuclei, TLE4 expression is used to identify nuclei with low (yellow), medium (orange), and high (red)
TLE4 expression levels. Based on a manually determined TLE4 expression threshold, all TLE4-expressing nuclei within the ROI are determined to be podocytes.
FIGURE 2 | Podometric analysis demonstrates correlation between reduced podocyte density and disease severity in Diabetic Nephropathy (A) Representative
images of glomeruli from healthy control tissue and Grades I–IV of Diabetic Nephropathy cohort. GLEPP1 (red) was used as a glomerular marker, TLE4 (green) was
used as a nuclear podocyte marker, Hoechst (blue) was used as a nuclear marker. (B) Podocyte nuclear density (n per 106um3) in healthy vs. Grade I/II vs. Grade
III/IV of Diabetic Nephropathy (**p < 0.01 and ***p < 0.001). (C) Glomerular volume per podocyte (×103um3) in Grade I/II vs. Grade III/IV in Diabetic Nephropathy
(*p < 0.05). (D) Podocyte number per glomerular tuft in Grade I/II vs. Grade III/IV in Diabetic Nephropathy (*p < 0.05). (E) Glomerular tuft volume (x106 um3) in
Grade I/II vs. Grade III/IV in Diabetic Nephropathy (ns, not significant).
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FIGURE 3 | Loss of nuclear YAP correlates with disease severity in Diabetic Nephropathy (A) Representative images of glomeruli from healthy renal cortical tissue
and from Grade I–IV Diabetic Nephropathy cases stained with TLE4 (red) as a podocyte nuclear marker, YAP (green) and Hoechst (blue) as a nuclear marker.
Magnification: 20×. Scale bar = 100 µm. (B) Ratio of YAP-positive nuclei (N-YAP/TE4+DAPI/glom) based on histological classification of disease (Grade I-II vs.
Grade III-IV). Values expressed as mean ± SD. ***p < 0.001, Student’s t-test, unpaired. (C) Assessment of the relationship between clinical parameters (proteinuria,
eGFR, serum creatinine, hematuria) and ratio of YAP-positive podocyte nuclei. (i) Proteinuria v. N-YAP/TLE4+DAPI/glom ratio, linear regression, *p = 0.024 (ii) Serum
creatinine (s-Cr) v. N-YAP/TLE4+DAPI/glom ratio, p = 0.6 (iii) Estimated glomerular filtration rate (eGFR) v. N-YAP/TLE4+DAPI/glom ratio, p = 0.7. Correlation
between variables was evaluated by least-squares linear regression.
with an average of 137 ± 19 podocytes per tuft in Grade I/II
cases as compared to an average of 85 ± 17 podocytes per
tuft in Grade III/IV cases (p < 0.05) (Figure 2D). However,
when comparing glomerular tuft volume between Grade I/II
and Grade III/IV cases, no significant difference was observed
(Figure 2E). Collectively, the podometric analysis of this cohort
demonstrates that podocyte density significantly decreases in late
stage Diabetic Nephropathy, consistent with other previously
published findings (Pagtalunan et al., 1997; Meyer et al., 1999;
Steffes et al., 2001; White et al., 2002).
Loss of Nuclear YAP in Late Grade
Diabetic Nephropathy
While both cytoplasmic and nuclear YAP expression was
observed in healthy tissue, we observed cytoplasmic translocation
of YAP in late grade Diabetic Nephropathy (Figures 3A,B).
We then calculated nuclear YAP per podocyte per glomerulus,
a metric comparable to that previously used to calculate
podocyte expression of nuclear dendrin (Asanuma et al.,
2011). This analysis demonstrated a significant decrease in
nuclear YAP in Grade I/II Diabetic Nephropathy relative
to healthy tissue (Figure 3B). A correlation was observed
between podocyte nuclear YAP expression and proteinuria
that achieved significance at p = 0.02, but the evidence
that there is a direct association between podocyte nuclear
YAP expression and proteinuria is not strong (r2 = 0.48),
while other clinical parameters including eGFR and serum
creatinine showed no significant correlation with nuclear YAP
expression (Figure 3C).
Recovery of YAP Following Exposure to
High Glucose and Hypoxia in vitro
To address whether podocyte injury was reversible, we
then assessed the expression and localization of YAP in
human podocytes in vitro. Total YAP protein expression
decreased following injury with 30 mM glucose, hypoxia,
and 25 µg/ml PAN (Figure 4A). YAP expression was
partially recovered in podocytes treated with high glucose
following 5 day washout, whereas cells exposed to hypoxia
completely recovered expression following washout and
return to normoxia for 5 days. Endogenous nuclear YAP was
present in healthy differentiated podocytes in vitro based
on immunofluorescence and confocal microscopy imaging
(Figure 4B). The induction of stress (by 30mM glucose, hypoxia,
or PAN treatment) resulted in reduced endogenous nuclear
YAP expression, which was partially recovered following 5





Given that cytoskeletal rearrangement is known to be a pivotal
step in podocyte foot process effacement and subsequent
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FIGURE 4 | Podocyte stress response induces reversible cytoplasmic translocation of YAP in vitro (A) Western blots for YAP comparing differentiated control
podocytes, injured podocytes (i) 30 mM glucose, (ii) hypoxia (0.5% O2), (iii) 25 µg/mL PAN, and 5 day washout of injury condition or return to normoxia. β-Actin and
GAPDH were used as loading controls. (B) Representative immunofluorescence images of YAP expression (red) in podocytes treated with (i) 30mM glucose, (ii)
hypoxia (0.5% O2), and (iii) 25 µg/mL PAN compared to differentiated control and 5 day washout of injury condition. DAPI (blue) detects nuclei. Magnification, 40×.
Scale bar = 50 µm.
detachment, we next asked whether YAP translocation during
podocyte stress-response precedes cytoskeletal rearrangement.
Interestingly, following 5 min of treatment with Blebbistatin,
a well characterized specific inhibitor of non-muscle myosin,
there was a significant decrease in the percentage of cells with
nuclear YAP (82.1% ± 1.5% vs. 5.2% ± 1.8%) (Figures 5A,B).
Following 2 h of Blebbistatin treatment, YAP was localized
exclusively in the cytoplasm, and cytoskeletal structure was non-
striated and disorganized (Figure 5A). Having identified that
cytoplasmic translocation of YAP during non-muscle myosin
inhibition occurs prior to cytoskeletal rearrangement, we then
asked whether inhibition of nuclear export would retain the
nuclear YAP phenotype during podocyte stress-response. To test
this, human podocytes were cultured in glucose in addition to
Leptomycin B, a known inhibitor of nuclear export which targets
CRM1, a receptor for the nuclear export signal of proteins.
While glucose treatment resulted in cytoplasmic translocation
of YAP as previously observed, co-culture with glucose and
Leptomycin B resulted in retention of nuclear YAP, comparable
to the control phenotype (86.3% ± 1.8% vs. 70.3% ± 3.6%)
(Figures 5C,D).
DISCUSSION
Progression of glomerular disease resulting from diabetes has
been characterized by decreased podocyte density (Pagtalunan
et al., 1997; Steffes et al., 2001) which can result from
podocyte apoptosis or detachment of viable podocytes into
the urine (Petermann et al., 2004). Podometric methodology
has been previously used to analyze podocyte density in
aging glomeruli (Hodgin et al., 2015) as well as in transplant
glomeruli (Yang et al., 2015), and has been highlighted as
a potential tool for glomerular disease management (Kikuchi
et al., 2015). Here, we present an amended and streamlined
methodology for podometric staining and image analysis
by multiplexing TLE4 and GLEPP1 primary antibodies for
immunofluorescence, and utilizing image analysis with Definiens
software to allow for automated detection and quantification
of glomerular metrics and podocyte number across a cohort
of tissue slides.
The podometric methodology developed herein offers two
advantages over the existing methodology. First, by multiplexing
primary antibodies, immunofluorescence can be performed for
both TLE4 and GLEPP1 simultaneously on the same tissue
section, without requiring removal of a coverslip. By streamlining
the protocol, we make its use in a clinical setting a feasible
goal. The second advantage is the incorporation of automated
image analysis for quantification of the variables required for
calculation of podocyte density. Incorporation of automated
image analysis allows for automated batch analysis of tissue
sections, and increases the efficiency of the methodology, making
it more suitable as a prognostic tool in a clinical setting. We
stratified the cohort into early grade vs. late grade Diabetic
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FIGURE 5 | YAP translocation precedes cytoskeletal rearrangement during podocyte stress response (A) Immunofluorescence staining demonstrates F-Actin (green)
and YAP (red) localization in podocytes treated with non-muscle myosin inhibitor, Blebbistatin. DAPI (blue) detects nuclei. (B) Quantification of percentage of nuclear
YAP positive cells following Blebbistatin treatment. 100 cells per timepoint per experiment were assessed for YAP localization, N = 3. ***p < 0.001, one-way ANOVA,
multiple comparisons test, data presented as mean ± SD. (C) Immunofluorescence staining demonstrates YAP (red) and DAPI (blue) staining in podocytes treated
with glucose, glucose + vehicle, and glucose + Leptomycin B. Magnification, 40×. Scale bar = 50 µm. (D) Quantification of cells expressing nuclear YAP in
immunofluorescence images of all conditions. One way ANOVA, multiple comparisons test, data presented as mean ± SD, ****p < 0.0001, and N = 3.
Nephropathy as defined by the pathological classification detailed
by Tervaert et al. (2010). We demonstrate decreased podocyte
nuclear density in Grades III and IV relative to Grades I
and II, consistent with previous findings of podocyte loss in
both type I and type II diabetes (Pagtalunan et al., 1997;
Steffes et al., 2001).
Since recent publications (Schwartzman et al., 2016; Rinschen
et al., 2017; Bonse et al., 2018) have identified YAP as an integral
player in podocyte stress response through both mechanosensing
and Hippo pathway signaling, we were interested in assessing
YAP localization in human Diabetic Nephropathy cases through
machine learning image analysis, and further investigating
the sequence of events resulting in YAP translocation and
cytoskeletal rearrangement during podocyte stress response
in vitro. Although we were limited to a small cohort, we
observed loss of nuclear YAP in podocytes in late grade
Diabetic Nephropathy, most notably in Grade IV cases, and
we observed nuclear YAP in healthy differentiated human
podocytes in vitro. Given previously reported observations that
YAP localization was specific to substrate stiffness in vitro,
and that substrate stiffness is known to affect cytoskeletal
integrity, we asked whether YAP translocation during stress
response preceded cytoskeletal rearrangement, as this sequence
of events would have important implications for developing
strategic therapeutic approaches. Interestingly, we observed
that Blebbistatin treatment induced cytoplasmic translocation
of YAP prior to cytoskeletal rearrangement, suggesting that
YAP may play a role in regulating cytoskeletal dynamics in
human podocytes. Collectively, our observations in clinical
tissue and in vitro warrant further investigation of the
interplay between YAP and cytoskeletal integrity in maintaining
podocyte viability.
To conclude, while biopsy of Diabetic Nephropathy cases is
not common clinical practice and thus limits the cohort available
for future studies, the amended podometric methodology
presented herein demonstrates technical improvement for
obtaining podometric data, and a streamlined process for
quantitative image analysis which may be used in a clinical
setting as a diagnostic tool for other glomerular diseases
where obtaining a biopsy is standard clinical practice, such
as FSGS. Additionally, we document early translocation of
YAP which precedes cytoskeletal rearrangement during stress-
response, suggesting that YAP may serve as a pivotal target early
on in glomerular disease onset.
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